scorecardresearch
Follow Us:
Sunday, July 03, 2022

Covid jabs get market approval for use in adults, with conditions

🔴 While India continues to report a surge in new cases, the Health Ministry on Thursday said “there is an early indication of plateau” in Covid-19 cases being reported in certain geographies.

By: Express News Service | New Delhi |
January 28, 2022 3:39:20 am
Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin, Covid, Covid-19, Covid vaccine, Covid-19 vaccine, vaccination, jabs, shots, coronavirus, coronavirus vaccine, Indian Express, India news, current affairs, Indian Express News Service, Express News Service, Express News, Indian Express India NewsWith the Drugs Controller General of India approving upgrade of status for Covishield and Covaxin, the two vaccines will have to comply with three broad conditions. (AP/File)

More than a year after it granted permission for restricted emergency use of Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin vaccines against Covid-19, the country’s drug regulator on Thursday upgraded the two vaccines by granting market authorisation in adult population, with certain conditions.

While India continues to report a surge in new cases, the Health Ministry on Thursday said “there is an early indication of plateau” in Covid-19 cases being reported in certain geographies. It said six states are recording a decline in cases and positivity: Maharashtra, Uttar Pradesh, Delhi, Odisha, Haryana, and West Bengal.  It, however, emphasised that required precautions need to be continued.  It said six states continue to record high cases and increase in positivity rate: Karnataka, Kerala, Tamil Nadu, Gujarat, Andhra Pradesh, and Rajasthan.

With the Drugs Controller General of India approving upgrade of status for Covishield and Covaxin, the two vaccines will have to comply with three broad conditions. The manufacturers will have to submit data of ongoing clinical trials overseas with due analysis on six-monthly basis.  Second, they will have to submit the safety data, including adverse event following immunisation, with due analysis on six-monthly basis. Third, the two vaccines will be supplied for “programmatic setting”, and all vaccinations done within the country to be recorded on CoWIN platform and Adverse Event Following Immunization, Adverse Event of Special Interest shall continue to be monitored, the ministry said.

Best of Express Premium
Get inspired: Why did Sardar Patel say that civil servants must not take ...Premium
NITI Aayog-commissioned report which studied 3 orders by Supreme Court, 2...Premium
Inside Track: Amit Shah’s strategy for Maharashtra and FadnavisPremium
Tavleen Singh writes: Islamism has no place in IndiaPremium

Centre urges caution on lifting curbs

New Delhi: The Centre has asked states to exercise caution while lifting Covid-19 restrictions, as cases still remain high. On Thursday, the Union Home Ministry issued an order under Disaster Management Act, extending its earlier order of December 27 for covid containment till February 28.

In a letter to chief secretaries of all states, Home Secretary Ajay Bhalla wrote, “…there has been a steady increase in number of cases…active cases have increased to over 22 lakh. Though a majority of active cases are recovering fast and a low percentage of cases are in hospitals, it is still a matter of concern that 407 districts in 34 States & UTs are reporting a positivity rate of more than 10%….there is a need to exercise caution and vigilance.”

UPSC KEY Have you seen our section dedicated to helping USPC aspirants decode daily news in the context of their exams?

📣 Join our Telegram channel (The Indian Express) for the latest news and updates

For all the latest India News, download Indian Express App.

  • Newsguard
  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
  • Newsguard
0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Advertisement
Advertisement
Advertisement